6PK-16699-17455
4 vaccinations
4 coded responses
38 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 038 / NH
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-11
Registered in v-safe
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
-
2021-03-15
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: GoodFree text: Just wanted to mention that I got the shot on 3/9, had a sore arm as my only symptom on 3/10. But I didnt sign up for visage until 3/11, so my 3/10 sore arm did not get recorded! Just trying to give the complete picture. ThanksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-07-07
-
2021-10-06
Survey response — 6 months, dose 2MedDRA: Dermatitis, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Unspecified dermatitis, currently seeing a dermatologist. Started first week of August, last shot was 4/7.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-10
Dose 3 — Pfizer-BioNTech
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
-
2021-11-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-14
- 2021-11-21
- 2022-01-09
-
2022-03-31
Dose 4 — Pfizer-BioNTech
- 2022-04-10
- 2022-04-20
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
-
2022-06-30
Survey response — 3 months, dose 4MedDRA: Breakthrough COVID-19, Cough, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: GoodFree text: Breakthrough Covid case, 5/25-6/4. Started with sore throat only 5/25-5/26. Cough started 5/28 and was done by 6/3. Home test was done 5/31 and PCP was notified. Very mild overall, my body with the help of my 4 Pfizer shots fought & won the battleMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — 6 months, dose 4MedDRA: Cough, Laryngitis, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, coughing, laryngitisMedDRA releases: 2024-11 · check-in free text available
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
| 4 | 2022-03-31 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Just wanted to mention that I got the shot on 3/9, had a sore arm as my only symptom on 3/10. But I didnt sign up for visage until 3/11, so my 3/10 sore arm did not get recorded! Just trying to give the complete picture. Thanks
Release 10 — 6 months, dose 2
Symptoms: Unspecified dermatitis, currently seeing a dermatologist. Started first week of August, last shot was 4/7.
Release 12 — 3 months, dose 4
Symptoms: Breakthrough Covid case, 5/25-6/4. Started with sore throat only 5/25-5/26. Cough started 5/28 and was done by 6/3. Home test was done 5/31 and PCP was notified. Very mild overall, my body with the help of my 4 Pfizer shots fought & won the battle cut off by CDC
Release 12 — 6 months, dose 4
Symptoms: Sore throat, coughing, laryngitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dermatitis | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release